Platelet Metrics In Type 2 Diabetes: A Practical Tool For Assessing Vascular Complications
DOI:
https://doi.org/10.63682/jns.v14i28S.7332Keywords:
Type 2 Diabetes, Vascular Complications, Platelet indices, HbA1c, Blood ParametersAbstract
Background: Chronic metabolic disorder Type 2 Diabetes Mellitus (T2DM) is characterized by hyperglycemia, which is associated with a range of complications, particularly vascular complications that significantly contribute to morbidity and mortality among patients. The ability to predict these complications early is crucial for preventive strategies and patient management. This study provides an overview of the practicality of platelet parameters for predicting vascular complications in type 2 diabetes patients, highlighting their importance in diabetes management and the potential benefits of incorporating them into clinical practice as accessible and cost-effective biomarkers for early risk assessment and improved patient management in the context of a global health challenge.
Method: The study included 250 T2DM patients and 125 non-diabetic individuals. Participants were selected using convenience sampling from outpatient and inpatient departments. The diabetic group was further categorized based on the presence or absence of vascular complications. Laboratory analyses were conducted to determine HbA1C levels and platelet parameters. Data were analyzed using SPSS version 21.0, applying non-parametric methods to evaluate platelet indices, HbA1c levels, and demographic variables.
Result: Elevated HbA1c, platelet count, MPV (Mean Platelet Volume), and PDW (Platelet Distribution Width) values were observed in T2DM patients with vascular complications, distinguishing them from T2DM patients without such complications and healthy subjects. The patient with Diabetes Mellitus and vascular complications exhibited an MPV of 14.44 fL, PDW of 19.21%, and a platelet count of 488.8 x 10^3/µL. These values surpass the normal ranges, suggesting heightened platelet activity, size variability, and a prothrombotic state.
Conclusion: The integration of MPV and PDW platelet indices could be an economical approach to T2DM vascular risk management, potentially bettering healthcare in rural settings.
Downloads
Metrics
References
International Diabetes Federation. Facts & figures [Internet]. 2022. Available from: https://idf.org/about-diabetes/facts-figures/
World Health Organization. Diabetes [Internet]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
Biondi-Zoccai GG, Abbate A, Liuzzo G, Biasucci LM. Atherothrombosis, inflammation, and diabetes. J Am Coll Cardiol. 2003; 41(7):1071-7.
Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes. 2008; 26(2):77-82.
Riyas Basheer KB, Dinesh KVN, Rai S, Mohammed Arshak AT. Peripheral nerve excitability among males in type-2 diabetes mellitus with and without diabetic neuropathy: A cross-sectional study. Medical Science. 2022; 26(128):ms396e2427.
Vinik AI, Erbas T, Park TS, Nolan R, Pittenger GL. Platelet Dysfunction in Type 2 Diabetes. Diabetes Care. 2001; 24(8):1476-85.
Kakouros N, Rade JJ, Kourliouros A, Resar JR. Platelet function in patients with diabetes mellitus: from a theoretical to a practical perspective. Int J Endocrinol. 2011;2011:742719.
Shilpi K, Potekar RM. A study of platelet indices in type 2 diabetes mellitus patients. Indian J Hematol Blood Transfus. 2018; 34(1):115-20.
Ranjan RK, Ashraf S, Singh S, Singh HB, Kudesia M, Sharma R. Diabetes Disease Burden by Platelet Indices As Possible Biomarkers in Evaluation of Initial Vascular Risks in Grading Diabetes Mellitus Part I: Correlation of Platelet Dysfunction Indices With Hematopoietic and Biochemical Parameters. IOSR J Dent Med Sci. 2018; 17(10):33-52.
Manchanda J, Malik A. Study of platelet indices in pregnancy-induced hypertension. Med J Armed Forces India. 2020; 76(2):161-5.
Budak YU, Polat M, Huysal K. The use of platelet indices, plateletcrit, mean platelet volume and platelet distribution width in emergency non-traumatic abdominal surgery: a systematic review. Biochem Med (Zagreb). 2016; 26(2):178-93.
Pogorzelska K, Krętowska A, Krawczuk-Rybak M, Sawicka-Żukowska M. Characteristics of platelet indices and their prognostic significance in selected medical condition - a systematic review. Adv Med Sci. 2020; 65(2):310-5.
Pechlivani N, Ajjan RA. Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets. Front. Cardiovasc. Med. 2018; 5:1-13.
Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2020; 174(2):251-8.
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016; 37(3):278-316.
Sherwani SI, Khan HA, Ekhzaimy A, Masood A, Sakharkar MK. Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights. 2016; 11:95-104.
Akyol S, Yildiz B, Akilli NB, Canpolat U. Neutrophil-to-lymphocyte ratio and platelet count as novel biomarkers of diabetic nephropathy. Ther Apher Dial. 2022; 26(1):101-9.
Zhang J. View of Platelet indices in diabetics and influence of glycemic control - a hospital based study in North-East India. Int J Med Res Rev. 2019; 6(1):18-23.
Kim JH, Bae HY, Kim SY. Marker of Platelet Hyperreactivity in Diabetes Mellitus. Diabetes Metab J. 2013; 37(6):423-8.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
